Why is "Abexinostat" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-03 11:28:40
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Abexinostat entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-04-03 and was most recently seen on 2026-04-03.
Wikipedia Overview
Abexinostat is an experimental drug candidate for cancer treatment. It was developed by Pharmacyclics and licensed to Xynomic. As of 2013, it was in Phase II clinical trials for B-cell lymphoma. Pre-clinical study suggests the potential for treatment of different types of cancer as well.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Abexinostat granted FDA's Fast Track designation for the treatment of patients with relapsed or refractory follicular lymphoma - Lymphoma Hub
-
FDA Grants Fast Track Designation to Abexinostat for Fourth-Line Follicular Lymphoma - Targeted Oncology
-
Research study explores targeted therapy for recurrent high-grade glioma - Nebraska Medicine
-
ASCO GU 2019: RENAVIV: Pazopanib with or without Abexinostat in Patients with Locally Advanced or Metastatic Renal Cell Carcinoma - UroToday
-
HDAC Inhibitors Market Sees Upward Trajectory Across the 7MM During the Forecast Period (2025-2034) Driven by Innovation in Cancer Therapies | DelveInsight - PR Newswire
-
Servier abandons cancer drug collaboration with Pharmacyclics - PMLiVE
-
Identification and evaluation of Pharmacological enhancers of the factor VII p.Q160R variant - Nature
-
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.